|
Distress screening in endometrial cancer leads to disparity in referral to support services
|
January 12, 2022
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Gynecologic Oncology
|
|
Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes
|
January 11, 2022
|
PC3I Authors Anne Marie McCarthy |
Cancers (Basel)
|
|
Insurance-Mediated Disparities in Gynecologic Oncology Care
|
January 6, 2022
|
PC3I Authors Anna Jo Smith; Emily Ko |
Obstetrics & Gynecology
|
|
COVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices Committee
|
January 6, 2022
|
PC3I Authors Larry Shulman |
Journal of the National Comprehensive Cancer Network
|
|
BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients
|
January 6, 2022
|
PC3I Authors Alix Seif |
Microbiology Resource Announcements
|
|
Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer
|
January 6, 2022
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Cancer Medicine
|
|
How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope
|
January 6, 2022
|
PC3I Authors |
JACC CardioOncology
|
|
Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone
|
January 5, 2022
|
PC3I Authors Ronac Mamtani |
JAMA Network Open
|
|
Persistent Barriers to Colorectal Cancer Screening Completion Amid Centralized Outreach: A Mixed Methods Study
|
December 31, 2021
|
PC3I Authors Jocelyn Wainwright; Shivan Mehta; Katharine Rendle |
American Journal of Health Promotion
|
|
Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
|
December 25, 2021
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers
|
December 24, 2021
|
PC3I Authors Emily Ko; Justin Bekelman |
Gynecologic Oncology
|
|
Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes
|
December 17, 2021
|
PC3I Authors Larry Shulman |
Gynecologic Oncology
|
|
Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank
|
December 15, 2021
|
PC3I Authors Peter Gabriel |
Genetics in Medicine
|
|
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|
December 13, 2021
|
PC3I Authors Christopher A. D’Avella |
Journal of the National Comprehensive Cancer Network
|
|
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
|
December 11, 2021
|
PC3I Authors Samuel Takvorian; Daniel Lee; Roger Kim; Caleb M. Hearn; William Ferrell; Larry Shulman; Ronac Mamtani |
Journal of the National Cancer Institute
|
|
The Click
|
December 10, 2021
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Journal of Plastic, Reconstructive, and Aesthetic Surgery
|
|
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography
|
December 10, 2021
|
PC3I Authors Charu Aggarwal |
Cancers
|
|
Reconceptualizing Risk-Benefit Assessment of Novel Cancer Therapies to Expand Global Access and Reduce Worldwide Mortality
|
December 9, 2021
|
PC3I Authors Larry Shulman |
JAMA Oncology
|
|
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia
|
December 6, 2021
|
PC3I Authors Allison Barz Leahy; Alix Seif |
Blood Advances
|
|
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
|
December 6, 2021
|
PC3I Authors Allison Barz Leahy; Haley Newman |
Blood
|
